Finally, keep open communication with your healthcare team
What those articles rarely include is what the clinic actually prescribes, how it schedules two peptides with different injection times, what it does when a patient is already on a hormonal therapy, or why Epithalon is not simply added to whatever else is running
GLP-1 agonists have also been used for HS, a condition that is associated with metabolic syndrome, obesity, and systemic inflammation, which currently has limited treatment modalities
GLP-1 medications already slow stomach motility
For patients with severe obesity (BMI 40 kg/m or 35 kg/m with comorbidities) who have not achieved adequate weight loss with non-surgical interventions, bariatric surgery may be considered following specialist assessment, as outlined in NICE CG189
Safety matters most when you have thyroid cancer risks or MEN2 history